The Global Market for Next-Generation Sequencing Tests Continues Its Torrid Pace

Por Phillips, Kathryn A., Douglas, Michael P.
Publicado no J Precis Med (2018)

Cellular Fatty Acid Composition of Lautropia mirabilis

Por Daneshvar, Maryam I., Douglas, Michael P., Weyant, Robbin S.
Publicado em 2001

Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs

Por Phillips, Kathryn A., Trosman, Julia R., Douglas, Michael P.
Publicado no JAMA (2019)

Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions

Por Deverka, Patricia A., Douglas, Michael P., Phillips, Kathryn A.
Publicado no Value Health (2020)

Private Payer and Medicare Coverage for Circulating Tumor DNA Testing: A Historical Analysis of Coverage Policies from 2015 – 2019

Por Douglas, Michael P., Gray, Stacy W., Phillips, Kathryn A.
Publicado no J Natl Compr Canc Netw (2020)

Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review

Por Palomaki, Glenn E., Melillo, Stephanie, Marrone, Michael, Douglas, Michael P.
Publicado no Genet Med (2013)

“What Goes Around Comes Around”: Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine

Por Phillips, Kathryn A., Douglas, Michael P., Trosman, Julia R., Marshall, Deborah A.
Publicado no Value Health (2017)

Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?

Por Phillips, Kathryn A., Deverka, Patricia A., Hooker, Gillian W., Douglas, Michael P.
Publicado no Health Aff (Millwood) (2018)

New Medicare Coverage Policy for Next-Generation Tumor Sequencing: A Key Shift in Coverage Criteria With Broad Implications Beyond Medicare

Por Phillips, Kathryn A., Trosman, Julia R., Weldon, Christine B., Douglas, Michael P.
Publicado no JCO Precis Oncol (2018)

Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review

Por Palomaki, Glenn E., Bradley, Linda A., Douglas, Michael P., Kolor, Katherine, Dotson, W. David
Publicado em 2009

Key emerging themes for assessing the cost-effectiveness of reporting incidental findings

Por Phillips, Kathryn A., Ladabaum, Uri, Pletcher, Mark J., Marshall, Deborah A., Douglas, Michael P.
Publicado no Genet Med (2015)

Availability and payer coverage of BRCA1/2 tests and gene panels

Por Clain, Elizabeth, Trosman, Julia R, Douglas, Michael P, Weldon, Christine B, Phillips, Kathryn A
Publicado no Nat Biotechnol (2015)

“Economic Evidence on Identifying Clinically Actionable Findings with Whole Genome Sequencing: A Scoping Review”

Por Douglas, Michael P., Ladabaum, Uri, Pletcher, Mark J., Marshall, Deborah A., Phillips, Kathryn A.
Publicado no Genet Med (2015)

Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology

Por Garfeld, Susan, Douglas, Michael P, MacDonald, Karen V, Marshall, Deborah A, Phillips, Kathryn A
Publicado no Per Med (2015)

Private Payer Coverage Policies for Whole Exome Sequencing (WES) in Pediatric Patients: Trends Over Time and Analysis of Evidence Cited

Por Douglas, Michael P., Parker, Stephanie L., Trosman, Julia R., Slavotinek, Anne M., Phillips, Kathryn A.
Publicado no Genet Med (2018)

The economic value of personalized medicine tests: what we know and what we need to know

Por Phillips, Kathryn A., Sakowski, Julie Ann, Trosman, Julia, Douglas, Michael P., Liang, Su-Ying, Neumann, Peter
Publicado em 2013

Genomic Sequencing: Assessing The Health Care System, Policy, And Big-Data Implications

Por Phillips, Kathryn A., Trosman, Julia, Kelley, Robin K., Pletcher, Mark J., Douglas, Michael P., Weldon, Christine B.
Publicado em 2014

Decision-Making on Medical Innovations in a Changing Healthcare Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies

Por Trosman, Julia R., Weldon, Christine B., Douglas, Michael P., Deverka, Patricia A., Watkins, John, Phillips, Kathryn A.
Publicado no Value Health (2017)

Perspectives of U.S. Private Payers on Insurance Coverage for Pediatric and Prenatal Exome Sequencing – Results of a study from the Program in Prenatal and Pediatric Genomic Sequen...

Por Trosman, Julia R., Weldon, Christine B., Slavotinek, Anne, Norton, Mary E., Douglas, Michael P., Phillips, Kathryn A.
Publicado no Genet Med (2019)

Payer Decision-Making for Next Generation Sequencing-Based Genetic Tests: Insights from cell-free DNA prenatal genetic screening

Por Dervan, Andrew P., Deverka, Patricia A., Trosman, Julia R., Weldon, Christine B., Douglas, Michael P., Phillips, Kathryn A.
Publicado no Genet Med (2016)